EndoTODAY | EndoATLAS | Outpatient Clinic

Parasite | Esophagus | Stomach | Cancer | ESD

Home | Guide | Author | Subscription | Links


[¼­¿ï´ë ºÐ´çº´¿ø Ư°­ - À§Àå°ü ¸²ÇÁÁ¾]

Á¸°æÇÏ´Â ¼ÛÀμº ¼±»ý´ÔÀÇ ÃÊ´ë·Î ¼­¿ï´ë ºÐ´çº´¿ø¿¡¼­ ¾Æħ Ư°­À» ÇÏ¿´½À´Ï´Ù. Àº»ç´Ô ¾Õ¿¡¼­ °­ÀÇÇÑ´Ù´Â °ÍÀº ´Ã ¶³¸®´Â ÀÏÀÔ´Ï´Ù. ¼±»ý´Ô, °¨»çÇÕ´Ï´Ù. ´Ã °Ç°­ÇϽʽÿä.

½Ã°£: 2017³â 1¿ù 24ÀÏ ¿ÀÀü 8½Ã

Àå¼Ò: ºÐ´ç¼­¿ï´ëº´¿ø º»°ü 1µ¿ 11Ãþ ȸÀǽÇ

°­ÀÇ ÈÄ ÁúÀÇ ÀÀ´ä. ¾à°£ û¹®È¸ °°Àº ºÐÀ§±â???

Fellow ¼±»ý´Ôµé°ú ÇÔ²² (´ëºÎºÐ EndoTODAY ¾Öµ¶ÀÚÀ̽É)

[Fellow ¼±»ý´Ôµé°ú »çÁøÀ» Âï°Ô µÈ ¿¬À¯ - »çÁøÀ» º¸³»ÁֽŠ¼±»ý´ÔÀÇ ¸ÞÀÏ¿¡¼­ ¿Å±è]
º¸Åë °­ÀÇ°¡ ÀÏÂï ³¡³ª¸é ±³¼ö´ÔµéÀ» Æ÷ÇÔÇÑ ÀüÅëÀûÀÎ ´Üü»çÁøÀ» Âï´Âµ¥, ¿À´ÃÀº ´Ùµé ¿ÀÀü ÀÏÁ¤À¸·Î ¼­µÑ·¯ ¶°³ª´Â ºÐÀ§±â¿´½À´Ï´Ù. ÀÌ °æ¿ì ÀüÀÓÀǵ鵵 »Ô»ÔÀÌ Èð¾îÁ®¼­ ÀÚ±â ÀÏÀ» ÇÏ´Â °æ¿ì°¡ ¸¹Àºµ¥ ¿À´ÃÀº ƯÀÌÇÏ°Ô ¹®¹Û¿¡¼­ ¿©·¯ ÀüÀÓÀǵéÀÌ ÂÞ»ÄÂÞ»Ä ¸Á¼³ÀÌ¸ç ¼­ ÀÖ¾ú½À´Ï´Ù.
"°°ÀÌ »çÁø Çѹø Âï°í ½ÍÀºµ¥.. ûÇصµ µÉ±î?"
"¾ß ÀÌ·²¶§ ¾ÈÂïÀ¸¸é ¾ðÁ¦ Âï¾î"
...¸¶Ä¡ ½ºÅ¸¸¦ óÀ½ ½Ç¹°·Î º¸´Â ÁßÇлýµé°°Àº ºÐÀ§±â¿´°í¿ä ^^;; ÀÌ·± ÀûÀÌ ÀDZ¹ ¿ª»ç»ó óÀ½ÀÔ´Ï´Ù. Æò¼Ò ÀúÈñµé ¸ðµÎ EndoTODAYÀÇ ¿­·ÄÇÑ ¾Öµ¶ÀÚ¿©¼­ ¿ë±â³»¾î ±³¼ö´Ô°ú »çÁøÀ» ÂïÀº °ÍÀ» ´ë´ÜÇÑ ¿µ±¤À¸·Î »ý°¢ÇÏ°í ÀÖ½À´Ï´Ù. ´Ù½Ã Çѹø °¨»çµå¸³´Ï´Ù.


1. °­ÀÇ ³»¿ë. À§Àå°ü ¸²ÇÁÁ¾

PPT PDF 9 M

À§Àå°ü ¸²ÇÁÁ¾ ³»½Ã°æ Áø´ÜÀ» Áß½ÉÀ¸·Î °­ÀÇ ³»¿ëÀ» ²Ù¸ìÀ¸¸é MALT ¸²ÇÁÁ¾ ºÐ¾ß´Â workup ¹× Ä¡·á¿¡ ´ëÇÏ¿© ¾à°£ ´Ù·ð½À´Ï´Ù. À§Àå°ü ¸²ÇÁÁ¾ ³»½Ã°æ Áø´Ü¿¡ ´ëÇÑ °³ÀÎÀû ÀÇ°ßÀ» °­Á¶Çß½À´Ï´Ù. .

1) À§Àå°ü ¸²ÇÁÁ¾Àº Á¡¸·ÇϺ´¼Òó·³ º¸ÀÌ´Â °æ¿ìµµ ÀÖÀ¸³ª Á¡¸·º´¼ÒÀÎ °æ¿ì°¡ ´õ ¸¹½À´Ï´Ù.

2) ¾Æ·¡¿Í °°Àº °æ¿ì¿¡´Â ¸²ÇÁÁ¾À» ÀǽÉÇÏ´Â °ÍÀÌ ÁÁ½À´Ï´Ù.

¸²ÇÁÁ¾Àº Á¾·ù°¡ ¸¹¾Æ¼­ ¾î¶»°Ô Á¢±ÙÇÏ´Â °ÍÀÌ ÁÁÀ»Áö ÆÇ´ÜÀÌ ¾î·Æ½À´Ï´Ù. ¾Æ·¡¿Í °°Àº ¼ø¼­¸¦ ±ÇÇÕ´Ï´Ù.

  1. B ¼¼Æ÷ÀÎÁö T ¼¼Æ÷ÀÎÁö ±¸ºÐÇÑ´Ù. --> T ¼¼Æ÷¸é ´ëºÎºÐ Ç×¾ÏÄ¡·á
  2. B ¼¼Æ÷ Áß MALT ¸²ÇÁÁ¾ÀÎÁö ¾Æ´ÑÁö ±¸ºÐÇÏ´Ù. --> MALT ¸²ÇÁÁ¾ÀÌ¸é ´ëºÎºÐ Helicobacter Á¦±ÕÄ¡·á
  3. ´Ù¸¥ °ÍµéÀº °¢ÀÚ °³º° Áø´Ü¿¡ µû¶ó Ä¡·áÇÑ´Ù.


¼ÛÀμº ¼±»ý´Ô²²¼­´Â MALTomaÀÇ ¿ª»ç¿¡ ´ëÇÏ¿© °£´ÜÈ÷ ¼³¸íÇØ Áֽø鼭 °ú°Å¿¡´Â pseudolymphoma·Î ºÎ¸¥ ÀûÀÌ ÀÖ¾ú´Ù°í comment Çϼ̽À´Ï´Ù.

Sleisenger 5ÆÇ (1993). MALT lymphomaÀÇ pathology¸¦ ¼³¸íÇÏ´Â ºÎÀ§¿¡ "includes pseudolymphoma"¶ó´Â ºÎºÐÀÌ ÀÖÀ½.


[ÁúÀÇ ÀÀ´ä]

ÁúÀÇ ÀÀ´ä ½Ã°£¿¡´Â ÁÖ·Î MALToma¿¡ ´ëÇÑ Åä·ÐÀ» ÇÏ¿´½À´Ï´Ù. ¼ÛÀμº ¼±»ý´Ô°ú ¿©·¯ ´Ù¸¥ ¼±»ý´ÔµéÀÇ ³¯Ä«·Î¿î Áú¹®ÀÌ °è¼ÓµÇ¾ú½À´Ï´Ù. Á¸°æÇÏ´Â ½º½Â´Ô ¾Õ ±äÀåµÈ »óÅ·Π´äº¯À» ÇÏ¿´Áö¸¸ ¸¹ÀÌ ºÎÁ·ÇÑ °Í °°½À´Ï´Ù. ±×·¡¼­ Á¶±Ý Á¤¸®ÇØ º¸¾Ò½À´Ï´Ù.

[2017-1-24. Áú¹®]

MALT ¸²ÇÁÁ¾ÀÌ ¾ÏÀ̶ó°í »ý°¢ÇϽʴϱî?

[2017-1-24. ÀÌÁØÇà ´äº¯]

¾î·Á¿î Áú¹®ÀÔ´Ï´Ù. ¿Ö³ÄÇÏ¸é ¾Ï(cancer)ÀÇ Á¤ÀÇ°¡ ¸íÈ®ÇÏÁö ¾Ê±â ¶§¹®ÀÔ´Ï´Ù.

Uncontrolled growth, metastasis¸¦ ¾ÏÀÇ ÁÖµÈ Æ¯Â¡À¸·Î º»´Ù¸é MALT ¸²ÇÁÁ¾ÀÇ ´ëºÎºÐÀº ¾ÏÀ̶ó°í ºÎ¸£±â ¾î·Æ½À´Ï´Ù. ¾Æ¹«¸® ¿À·¡ ±â´Ù·Áµµ uncontrolled growth¸¦ ÇÏÁö ¾Ê°í metastasisµµ º¸ÀÌÁö ¾Ê±â ¶§¹®ÀÔ´Ï´Ù. ±×·¯³ª MALT ¸²ÇÁÁ¾ Áß ÀϺδ ºÐ¸í uncontrolled growth¿Í metastasis(°ñ¼ö ħÀ±À̳ª ¸²ÇÁÀý ħÀ±)¸¦ º¸ÀÔ´Ï´Ù. Áï MALT ¸²ÇÁÁ¾Àº heterogeneous ÇÕ´Ï´Ù. Á¼Àº ÀǹÌÀÇ ¾ÏÀÇ Æ¯¼ºÀ» °¡Áö°í ÀÖ´Â °Íµµ ÀÖÁö¸¸, ±×·¸Áö ¾ÊÀº Á¾·ùµµ ÀÖ½À´Ï´Ù. ÀÌ µÑÀÇ ±¸ºÐÀÌ ¾î·Æ±â ¶§¹®¿¡ ±×³É Àüü¸¦ ¾ÏÀ̶ó°í ºÎ¸¦ ¼ö ¹Û¿¡ ¾ø½À´Ï´Ù. ¾Æ´Ñ °Í °°Àº °Íµµ ¾ÆÁÖ ¸¹Áö¸¸ ±×³É ¸ðµÎ¸¦ ¾ÏÀ̶ó°í ºÎ¸¨´Ï´Ù.

¾ÏÀÌ Àß Á¤ÀǵǾî Àִ åÀº ¾ø´Â °Í °°½À´Ï´Ù. ¾Æ·¡ µÎ¹ø°´Â Á¦°¡ º»°ú 2Çг⠽ÃÀý¿¡ ¹è¿î block Ã¥ÀÔ´Ï´Ù. ¾Ç¼º Á¾¾ç°ú ¾ç¼º Á¾¾çÀ» ³ª´©´Â Ç¥°¡ Á¦½ÃµÇ¾î ÀÖ°í ¾Ç¼º Á¾¾çÀ» ¾ÏÀ̶ó°í Á¤ÀÇÇÏ°í ÀÖ½À´Ï´Ù. ±×·±µ¥ ¹®Á¦´Â ±× Áß°£µµ ¸¹´Ù´Â °ÍÀÔ´Ï´Ù. ÀϺΠƯ¼ºÀº ¾Ï °°°í ÀϺΠƯ¼ºÀº ¾Ï °°Áö ¾ÊÀº Á¾·ù°¡ ÀÖ´Ù´Â ÀǹÌÀÔ´Ï´Ù. (Âü°í: EndoTODAY ¾Ï°ú ¾ÏÀÌ ¾Æ´Ñ °ÍÀ¸ ±¸ºÐ - ½Äµµ carcinoma in situ¿¡ ´ëÇÏ¿©)

¾ÏÀ» ¿Ö cancer¶ó°í ºÎ¸£´ÂÁö ±× ±â¿øÀ» Àß ¼³¸íÇÏ°í ÀÖ´Â ´ÜÇົ

¼­¿ï´ë block °úÁ¤ ±³°ú¼­

»ç½Ç ¼¼»óÀº analogÀÔ´Ï´Ù. ¾Ï°ú ¾ÏÀÌ ¾Æ´Ñ °Í, ÀÌ·¸°Ô µÎ °¡Áö·Î ¸íÈ®È÷ ³ª´­ ¼ö ¾ø´Â °ÍÀÌ Áúº´ÀÇ º»ÁúÀÔ´Ï´Ù. ¾ÏÀ̶ó°í ²À ³ª»Û °Íµµ ¾Æ´Ï°í ¾ÏÀÌ ¾Æ´Ï¶ó°í ¹Ýµå½Ã ÁÁÀº °Íµµ ¾Æ´Õ´Ï´Ù. ±×³É ÆíÀÇ»ó ÀÌ·¯ÀÌ·¯ÇÑ °æ¿ì¸¦ ¾ÏÀ̶ó°í ºÎ¸¦ »ÓÀÔ´Ï´Ù. ¾ÏÀÌ³Ä ¾ÏÀÌ ¾Æ´Ï³Ä¸¦ °¡Áö°í Àå³­Ä¡´Â ÀϺΠ¼¼·Â(¾Ïº¸Çè µî)ÀÌ ¹®Á¦ÀÎ °ÍÀÌÁö, ¾Ö¸ÅÇÑ Áúº´À» ¾Ö¸ÅÇÏ´Ù°í ¸»ÇÏ´Â Àǻ簡 ¹®Á¦ÀÎ °ÍÀº ¾Æ´Õ´Ï´Ù. (Âü°í: EndoTODAY MALToma ¾Ö¸ÅÇÑ °æ¿ì)

¿äÄÁµ¥ MALT ¸²ÇÁÁ¾À̶ó´Â Áø´Ü¿¡´Â ¾Ï °°Àº °Í°ú ¾Ï °°Áö ¾ÊÀº °ÍÀÌ ¼¯¿©ÀÖÁö¸¸, Á¤È®ÇÑ ±¸ºÐÀº ¾î·Æ±â ¶§¹®¿¡ ÆíÀÇ»ó ¸ðµÎ¸¦ ¾ÏÀ¸·Î ºÎ¸£°í ÀÖ´Â °Í ¾Æ´Ñ°¡ »ý°¢µË´Ï´Ù. (Âü°í: EndoTODAY MALToma)


[2017-1-24. Áú¹®]

10³â ÈÄ¿¡µµ MALT ¸²ÇÁÁ¾À̶ó´Â Áø´Ü¸íÀÌ »ì¾Æ³²À» °Í °°½À´Ï±î?

[2017-1-24. ÀÌÁØÇà ´äº¯]

Ȥ½Ã ¼¼ºÐÈ­µÇ¾î ÀϺδ ºüÁö°í ÀϺδ ³²°ÔµÉÁö ¸ð¸£°Ú½À´Ï´Ù¸¸, ¿ÏÀüÈ÷ »ç¶óÁú °Í °°Áö´Â ¾Ê½À´Ï´Ù.


[2017-1-24. Áú¹®]

Helicobacter negative MALToma´Â ¾î¶»°Ô ÇÏ°í °è½Ã´ÂÁö¿ä?

[2017-1-24. ÀÌÁØÇà ´äº¯]

Àú´Â Helicobacter À½¼º MALT ¸²ÇÁÁ¾À̶ó°í ÆÇ´ÜµÈ °æ¿ì¶óµµ ÀÏ´Ü Á¦±ÕÄ¡·á¸¦ ½ÃÇàÇÑ ÈÄ °æ°ú°üÂûÀ» ÇÕ´Ï´Ù. ¿µ È£ÀüÀÌ ¾øÀ¸¸é RT¸¦ ±ÇÇÕ´Ï´Ù. ÃÖ±Ù¿¡´Â ²À H. pylori serology¸¦ ÇÏ°í ÀÖ½À´Ï´Ù. Serology±îÁö À½¼ºÀ̾î¾ß¸¸ ÁøÁ¤ÇÑ H. pylori À½¼º MALToma ¾Æ´Ñ°¡ »ý°¢ÇÏ°í ÀÖ½À´Ï´Ù. (Âü°í: EndoTODAY Hp À½¼º MALToma)


[2017-1-24. Áú¹®]

MALT lymphoma°¡ gastric DLBCL (diffuse large B cell lymphoma)·Î ¹Ù²ï´Ù°í »ý°¢ÇϽʴϱî? ´Ù¸¥ ¸»·Î diffuse large B cell lymphoma of the stomachÀÌ MALT lymphoma¿¡¼­ ½ÃÀÛÇÏ´Â °ÍÀ¸·Î º¸½Ã´ÂÁö¿ä?

[2017-1-24. ÀÌÁØÇà ´äº¯]

Àú´Â 1997³âºÎÅÍ 2000³â 4¿ù±îÁö ±º´ë¿¡ ´Ù³à¿Ô½À´Ï´Ù. Á¦°¡ ±º´ë¿¡ °¡±â Àü MALT lymphoma´Â ºÐ¸íÈ÷ (1) high grade component°¡ ÀÖ´Â °æ¿ì¿Í (2) high grade component°¡ ¾ø´Â °æ¿ì·Î ³ª´µ¾ú½À´Ï´Ù.

Sleisenger 9th (2010). MALT ¸²ÇÁÁ¾¿¡ large cell component°¡ ¼¯¿© ÀÖ´Â °æ¿ì¿¡ ´ëÇÏ¿© ºñ±³Àû »ó¼¼È÷ ³íÀǵǰí ÀÖÀ½. MALToma¿Í diffuse large B cell lymphoma¸¦ spectrumÀ¸·Î ¼³¸íÇÏ°í ÀÖÀ½.

±×·±µ¥ Á¦°¡ ±º´ë¿¡ ´Ù³à¿Â ÈÄ »ìÆ캸´Ï MALTomaÀÇ ¹üÀ§°¡ (1) high grade component°¡ ¾ø´Â °æ¿ì·Î Ãà¼ÒµÇ¾î ÀÖ¾ú½À´Ï´Ù. ¾î¶»°Ô ÀÌ·¸°Ô º¯Çß´ÂÁö trace´Â ¾î·Á¿ü½À´Ï´Ù. ±×³É º´¸®ÀÇ»çµéÀÌ ¾ó··¶×¶¥ ¹Ù²Û °Í ¾Æ´Ñ°¡ ÃßÁ¤ÇÏ°í ÀÖ½À´Ï´Ù.

Àú´Â ÀüºÎ´Â ¾Æ´ÒÁö ¸ô¶óµµ ´ëºÎºÐÀÇ À§ ¸²ÇÁÁ¾Àº MALT Á¶Á÷¿¡¼­ ¹ß»ýÇÏ´Â °Í ¾Æ´Ñ°¡ ÃßÁ¤ÇÏ°í ÀÖ½À´Ï´Ù. ÀϺδ ÀÏÁ¤ ±â°£ÀÇ low grade MALToma ±â°£À» °ÅÃļ­ DLBCLÀÌ µÇ°ÚÁö¸¸, ´õ ¸¹Àº °æ¿ì´Â low grade MALToma ±â°£À» ¾ÆÁÖ Âª°Ô °ÅÄ¡°Å³ª ȤÀº ¾Æ¿¹ °ÅÄ¡Áö ¾Ê°í DLBCLÀÌ µÉ °Í °°½À´Ï´Ù. ±×·¡µµ ¼¼Æ÷ÀÇ ±â¿øÀº MALT Á¶Á÷ÀÏ °ÍÀ¸·Î ÁüÀÛÇÕ´Ï´Ù.


[2017-1-24. Áú¹®]

Colon MALToma µî extraintestinal MALT lymphoma¿¡ ´ëÇؼ­´Â ¾î¶»°Ô ÇÏ°í °è½Ã´ÂÁö¿ä?

[2017-1-24. ÀÌÁØÇà ´äº¯]

Áõ·Ê°¡ ¸¹Áö ¾Ê°í Á¦°¡ Áø·áÇÏ´Â ºÐ¾ß°¡ ¾Æ´Ï¶ó¼­ Á¤È®È÷ ´äº¯µå¸®±â ¾î·Æ½À´Ï´Ù. ÀÏ´Ü H. pylori Á¦±ÕÄ¡·á¸¦ ÇØ º¸±âµµ ÇÏ°í, RT¸¦ Çϱ⵵ ÇÕ´Ï´Ù. ÃÖ±Ù¿¡´Â flat adenoma·Î »ý°¢ÇÏ°í EMRÀ» ÇÑ È¯ÀÚ¿¡¼­ colon MALToma°¡ ³ª¿Â °æ¿ì°¡ ÀÖ´Â°Ô ±×³É °æ°ú°üÂû ÇÏ°í ÀÖ½À´Ï´Ù. ¾Æ·¡¿¡ ¿Å±é´Ï´Ù.


¿ÜºÎ ³»½Ã°æ¿¡¼­ cecum¿¡ 0.8cmÀÇ flat elevated lesionÀ¸·Î ÀÇ·ÚµÊ. Á¶Á÷°Ë»ç³ª ¿ëÁ¾ÀýÁ¦¼úÀº ½ÃÇàµÇÁö ¾ÊÀº »óÅ¿´À½.

º´¸®°á°ú "dense infiltration of small lymphocytes with lymphoid follicle formation and multifocal lymphoepithelial lesions, suggestive of extranodal marginal zone lymphoa of MALT"¿´À½. Staging workup¿¡¼­ ´Ù¸¥ ºÎÀ§ lymphoma´Â ¾ø¾úÀ½. Ãß°¡ Ä¡·á ¾øÀÌ 6°³¿ù ÈÄ ÃßÀû³»½Ã°æÀ» ÇÏ¿´°í ƯÀÌ ¼Ò°ßÀÌ ¾ø¾úÀ½.



© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.